Connect with us
[bsa_pro_ad_space id=12]

Brownstone Institute

Focused Protection: Jay Bhattacharya, Sunetra Gupta, and Martin Kulldorff

Published

24 minute read

From the Brownstone Institute

BY Gabrielle BauerGABRIELLE BAUER

If you express any misgivings about the Covid policies, people are quick to retort: OK, so what’s your solution? How do you propose we should have handled the pandemic instead? Three experts came up with an answer, which they put into writing and co-signed in the Massachusetts town of Great Barrington on October 4, 2020.

[This is an excerpt from the author’s new book Blindsight Is 2020, published by Brownstone.]

Nobody could fault their credentials. A public health expert focusing on infectious diseases and vulnerable populations, Stanford University professor Jay Bhattacharya doubles as a health economist. Sunetra Gupta, an epidemiology professor at Oxford University, specializes in immunology, vaccine development, and mathematical modeling of infectious diseases. Martin Kulldorff, a biostatistician and epidemiologist, ended an 18-year run as a Harvard University professor in 2021.

The strategy they proposed in the Great Barrington Declaration (GBD) flowed from a unique feature of the coronavirus: its unusually sharp and well-defined risk gradient. By the end of summer 2020, studies were confirming what the staff in every hospital already knew: “The risk [of dying of Covid] climbs steeply as the years accrue.” The CDC published an infographic that put this sharp gradient into relief: if you contracted the virus at age 75-84, your risk of dying from it was 3,520 times higher than if you caught it at age 5-17. Chronic conditions such as obesity, heart disease, and diabetes also bumped up the risk, though not nearly as much as age.

So here we had a virus that posed a significant risk to some people and a very small risk to others. At the same time we had lockdown policies that, for all their egalitarian pretensions, divided people rather neatly along class lines. To the professional couple with a chef’s kitchen and a subscription to four streaming services, lockdowns represented a chance to reconnect and revel in life’s simple pleasures, like home-baked olive bread and Humphrey Bogart movies. To the newly landed foreign student, dizzy with loneliness under his basement ceiling, not so much. Essential workers, for their part, were expected to bear the risks deflected by the laptop class.

This confluence of circumstances made it impossible not to consider the question: Might we give low-risk groups back their freedom while protecting more vulnerable people? That’s exactly what the GBD proposed. I’ve reproduced it here in abbreviated form:

Current lockdown policies are producing devastating effects on short and long-term public health. Keeping these measures in place until a vaccine is available will cause irreparable damage, with the underprivileged disproportionately harmed.

We know that vulnerability to death from COVID-19 is more than a thousand-fold higher in the old and infirm than the young. We know that all populations will eventually reach herd immunity and that this can be assisted by (but is not dependent upon) a vaccine. Our goal should therefore be to minimize mortality and social harm until we reach herd immunity. 

The most compassionate approach is to allow those who are at minimal risk of death to live their lives normally to build up immunity to the virus through natural infection, while better protecting those who are at highest risk. We call this Focused Protection. A comprehensive and detailed list of measures, including approaches to multi-generational households, can be implemented, and is well within the scope and capability of public health professionals. 

Those who are not vulnerable should immediately be allowed to resume life as normal. Arts, music, sport and other cultural activities should resume. People who are more at risk may participate if they wish, while society as a whole enjoys the protection conferred upon the vulnerable by those who have built up herd immunity.

Outside the context of Covid, there was nothing radical about the proposal. It aligned with pre-Covid pandemic guidance from such organizations as the WHO and CDC, which advised against blanket restrictions and put a premium on minimizing social disruption. It also capped off a growing unrest throughout the summer of 2020, when groups of experts in several countries began calling for a less aggressive approach to Covid—from Balanced Response in Canada to New Zealand’s Covid Plan B—and exhorting their governments to restore a more normal life for the lower-risk majority. The GBD emerged as the culmination of these rumblings, the anti-lockdown appeal that finally got the world’s attention. Quiet academics on the eve of its launch, Bhattacharya, Gupta and Kulldorff now had the global spotlight on their faces.

When the trio posted the document online, they invited supporters to co-sign it. The signature count grew very quickly for a few days—I know, because I watched the changing digits—and then screeched to a halt. The backlash began just four days after the GBD came out, when Francis Collins, then-director of the National Institutes of Health, called it the work of “three fringe epidemiologists” in an email to Fauci and other high-ranking colleagues. Evidently concerned about the media buzz surrounding the Declaration, he requested a “quick and devastating take down [sic] of its premises.”

Collins got his wish when an article by Yale University epidemiologist Gregg Gonsalves appeared in The Nation that same day. We’re not going to follow “some notion of the survival of the young and the fittest,” Gonsalves wrote—a rather elastic interpretation of “protect the vulnerable.” A few days later, the Lancet published a GBD rebuttal statement known as the John Snow Memorandum. Fauci himself described the GBD as “nonsense” and “dangerous.”

With Fauci’s blessing to bash the GBD, media pundits and online warriors happily obliged. Outrage flared up in print and on social media: Murderers! Covid deniers! They don’t care about the vulnerable! (Never mind that the whole strategy revolved around shielding the vulnerable.) “I started getting calls from reporters asking me why I wanted to ‘let the virus rip,’ when I had proposed nothing of the sort. I was the target of racist attacks and death threats,” Bhattacharya recalls. Rumors that the American Institute for Economic Research (AIER) was using the GBD trio to advance a libertarian agenda began to circulate. In fact, “AIER was kind enough to provide the venue for the meeting that led to the Great Barrington Declaration, but played no role in designing its content.”

Jeffrey Tucker, AIER’s senior editor at the time (and founder of the Brownstone Institute), explained to me that the group was “hoping to catalyze a discussion around the Covid policies. We had no idea where it would go or how big it would become.” 

The term “herd immunity” acquired dark undertones, with everyone forgetting that respiratory pandemics have ended with herd immunity throughout history. The misreading of the term as a callous and individualistic concept continues to puzzle Gupta, who notes that “herd immunity is actually a deeply communitarian idea” because broad societal immunity “is what ends up protecting the vulnerable.”

Suddenly personae non gratae, the GBD partners sought vainly to defend themselves to an audience that had already blocked its ears. Gupta, a life-long progressive, was relegated to publishing her thoughts in conservative news outlets. “I would not, it is fair to say, normally align myself with the Daily Mail,” she admitted in an article she wrote for the newspaper shortly after the GBD came out, adding that she was “utterly unprepared for the onslaught of insults, personal criticism, intimidation and threats that met our proposal.”

I had the opportunity to chat with all three members of the GBD team on separate group video calls. For the record, I cannot imagine a more sincere and gracious trio—the types of people my late mother would have called mensches. Had their critics spent an hour with them over nachos and craft beer, I’m confident the smear campaign against them would have fizzled right out.

Sometimes, a single word can make everything fall into place. The word “unpoetic,” which Gupta used to describe the Covid response, had this effect on me. It was the word I had been searching for all along, the key to what the stay-home-save-lives people were missing. It’s probably no coincidence that Gupta wears a second hat as an award-winning novelist, giving her mind a respite from the biomedical world view.

“It’s a crisis of pathos,” she said when I asked her to elaborate. “It’s a one-dimensional response to a multidimensional crisis. I call it an unpoetic response because it misses the soul of life, the things that give life meaning.”

If Gupta found the pandemic response lacking in poetry, she also decried its esthetics. Sitting at a restaurant table, breaking bread with your unmasked friends while the masked server grinds fresh pepper over your linguini…the “unbearable feudal aspect of it” offended her egalitarian sensibilities. “It echoes the caste system, [with] all sorts of rules about who can receive a drink of water from whom—all these completely illogical and highly unesthetic rules that are there to demolish the dignity of individuals.”

That same word, feudal, underpins Tucker’s analysis of the Covid restaurant closures. In one of his numerous essays, he notes that “the tavern, the coffee house, and the restaurant had a huge role in spreading the idea of universal rights.” The restaurant closures represented “a return to a pre-modern age in which only the elites enjoyed access to the finer things”—what Tucker calls a “new feudalism.”

As the pandemic progressed, Gupta continued to delight me with her insights—like the notion of shared responsibility for viral transmission. “It is fruitless to trace the source of infection to a single event,” she reflects in The Telegraph. “In our normal lives, many die of infectious disease but we collectively absorb the guilt of infecting them. We could not function as a society otherwise.”

Such a lovely way of putting it: we collectively absorb the guilt. Nobody has to worry about “killing grandma” because nobody is killing grandma. A pathogen enters our world and we divide its psychic weight among us, the burden made lighter for being shared. (It goes without saying that deliberately infecting someone falls into a different category, though I have yet to hear of anyone who seeks to do that.) But Covid culture “concentrated the blame that should have been dispersed within the community upon an individual,” Gupta says. And for individuals like Gupta, who spoke out publicly against a strategy sold to (and bought by) the public as necessary, the blaming and shaming culture knew no pity.

I had some idea of what Gupta and her GBD collaborators were going through, having received my share of invective when discussing Covid policies online: Go lick a pole and catch the virus. Have fun choking on your own fluids in the ICU. Name three loved ones you’re ready to sacrifice to Covid—do it now, coward. Enjoy your sociopathy.

None of these missives came from anyone who knew me personally, but after receiving enough of them I started to wonder if the shamers knew something I didn’t.

“What if the lockdown lovers are right?” I asked Dr. Zoom on one occasion. “What if I am a sociopath?”

“You’re not a sociopath.”

“How do you know?”

“A sociopath wouldn’t ask the question—plus sociopaths don’t introspect and you do nothing but introspect. You’re the queen of introspection.”

“Why do you think I do that? Is it a defense mechanism or something?

“See? You’re doing it again.”

I wrote an article about my experience with Covid shamers, which prompted people from all over the world to email their own stories to me. Many of them had it a lot worse than I did, their heterodox views having cost them jobs and friendships (and in one case, a marriage). Kulldorff tweeted a link to the article with an accompanying assertion that “shaming never is, never was, and never will be part of good public health practice.”

Also: it doesn’t work. Calling someone a troglodyte for opposing a mask mandate does not bring about a change of heart. It just invites resistance—or drives people underground, as Harvard epidemiologist Julia Marcus points out: “Shaming and blaming people is not the best way to get them to change their behavior and actually can be counterproductive because it makes people want to hide their behavior.”

Amid all the shouting and shaming, some public health experts asked reasonable questions about how the GBD architects proposed to shield the vulnerable from a virus allowed to spread freely in society. Bhattacharya, Gupta and Kulldorff had answers to that, but the time for a fair hearing had come and gone. The window of opportunity to explore a focused protection strategy, pried open for a week or two by the Declaration, slammed shut again. It wasn’t long before Facebook censored mentions of the document.

This was not a healthy state of affairs. As Harry Truman remarked in 1950, “once agovernment is committed to the principle of silencing the voice of opposition, it has only one way to go, and that is down the path of increasingly repressive measures.” Likewise, the dismissal of the GBD as a “dangerous idea” would not have impressed Supreme Court Justice Louis Brandeis, who wrote that “the essential character of a political community is both revealed and defined by how it responds to the challenge of threatening ideas” and that “fear of serious injury alone cannot justify oppression of free speech.” Is it just me, or were decision makers smarter back then?

With neither a Truman nor a Brandeis to defend them, the GBD creators no longer stood a chance in the public arena. Bhattacharya and Gupta turned their attention to Collateral Global, a UK charity devoted to documenting the harms of the lockdown policies, and Kulldorff joined the Brownstone Institute as a senior scholar. Which doesn’t mean they forgot about what happened. In August 2022, Bhattacharya and Kulldorff, along with two other doctors, joined the State of Missouri’s lawsuit against the federal government for quashing debate about Covid policies. In the court document, which begins with George Washington’s warnings against censorship, the plaintiffs accuse the US government of “open collusion with social-media companies to suppress disfavored speakers, viewpoints, and content.” With any luck, the case will rattle some closet doors.

In the early months of the pandemic, scientists concerned about lockdowns feared “coming out” in public. The GBD partners took one for the B team and did the dirty work. They paid a heavy price for it, including the loss of some personal friendships, but they held their ground. In print, on air, and on social media, Bhattacharya continues to describe lockdowns as “the single worst public health mistake in the last 100 years,” with catastrophic health and psychological harms that will play out for a generation.

It’s no longer unfashionable to agree with them. A National Post article written by four prominent Canadian doctors in late 2022 maintains that the “draconian Covid measures were a mistake.” A retrospective analysis in The Guardian suggests that, instead of going full bore on the lockdown strategy, we “should have put far more effort into protecting the vulnerable.” Even the sober Nature admits that lockdowns “exacerbate inequalities that already exist in society. Those already living in poverty and insecurity are hit hardest”—exactly the key takeaway from the Australian Fault Lines report released in October 2022.

Kulldorff captures this sea change in one of his tweets: “In 2020 I was a lonely voice in the Twitter wilderness, opposing lockdowns with a few scattered friends. [Now] I am preaching to the choir; a choir with a wonderful, beautiful voice.” The landscape has also become more hospitable for Bhattacharya, who in September 2022 received Loyola Marymount University’s Doshi Bridgebuilder Award, awarded annually to individuals or organizations dedicated to fostering understanding between cultures and disciplines.

Perhaps the concept of focused protection simply arrived too early for a frightened public to metabolize it. But the idea never died down completely, and after the paroxysms of moral indignation ran their course, it slowly grew a second skin. By September 2022, the tally of GBD co-signatories had surpassed 932,000, with over 60,000 of them from doctors and medical/public health experts. Not bad for a dangerous document by a trio of fringe epidemiologists. And would it be churlish to point out that the John Snow Memorandum maxed out at around 7,000 expert signatures?1

The GBD didn’t get every detail right, of course. Nobody could have anticipated, back in the fall of 2020, all the surprises the virus had in store for us. While reasonable at the time, the Declaration’s confidence in herd immunity proved overambitious. We now know that neither infection nor vaccination provides durable immunity against Covid, leaving people vulnerable to second (and fifth) infections. And for all their effect on disease severity, the vaccines don’t stop transmission, pushing herd immunity still further from reach.

Be that as it may, the GBD creators wrote a crucial chapter in the pandemic story. They planted seeds of doubt in a locked-in narrative. After all the insults were thrown, the seeds took root in our collective consciousness and may well have shaped policy indirectly. And as research continues to document the dubious benefits and profound harms of the maximum-suppression strategy, yesterday’s shamers and mockers are inching back toward the question: Could we have done it another way? Might focused protection have worked just as well, or better, and with considerably less damage?

Author

  • Gabrielle Bauer

    Gabrielle Bauer is a Toronto health and medical writer who has won six national awards for her magazine journalism. She has written three books: Tokyo, My Everest, co-winner of the Canada-Japan Book Prize, Waltzing The Tango, finalist in the Edna Staebler creative nonfiction award, and most recently, the pandemic book BLINDSIGHT IS 2020, published by the Brownstone Institute in 2023

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Brownstone Institute

FDA Exposed: Hundreds of Drugs Approved without Proof They Work

Published on

From the Brownstone Institute

By Maryanne Demasi

The US Food and Drug Administration (FDA) has approved hundreds of drugs without proof that they work—and in some cases, despite evidence that they cause harm.

That’s the finding of a blistering two-year investigation by medical journalists Jeanne Lenzer and Shannon Brownleepublished by The Lever.

Reviewing more than 400 drug approvals between 2013 and 2022, the authors found the agency repeatedly ignored its own scientific standards.

One expert put it bluntly—the FDA’s threshold for evidence “can’t go any lower because it’s already in the dirt.”

A System Built on Weak Evidence

The findings were damning—73% of drugs approved by the FDA during the study period failed to meet all four basic criteria for demonstrating “substantial evidence” of effectiveness.

Those four criteria—presence of a control group, replication in two well-conducted trials, blinding of participants and investigators, and the use of clinical endpoints like symptom relief or extended survival—are supposed to be the bedrock of drug evaluation.

Yet only 28% of drugs met all four criteria—40 drugs met none.

These aren’t obscure technicalities—they are the most basic safeguards to protect patients from ineffective or dangerous treatments.

But under political and industry pressure, the FDA has increasingly abandoned them in favour of speed and so-called “regulatory flexibility.”

Since the early 1990s, the agency has relied heavily on expedited pathways that fast-track drugs to market.

In theory, this balances urgency with scientific rigour. In practice, it has flipped the process. Companies can now get drugs approved before proving that they work, with the promise of follow-up trials later.

But, as Lenzer and Brownlee revealed, “Nearly half of the required follow-up studies are never completed—and those that are often fail to show the drugs work, even while they remain on the market.”

“This represents a seismic shift in FDA regulation that has been quietly accomplished with virtually no awareness by doctors or the public,” they added.

More than half the approvals examined relied on preliminary data—not solid evidence that patients lived longer, felt better, or functioned more effectively.

And even when follow-up studies are conducted, many rely on the same flawed surrogate measures rather than hard clinical outcomes.

The result: a regulatory system where the FDA no longer acts as a gatekeeper—but as a passive observer.

Cancer Drugs: High Stakes, Low Standards

Nowhere is this failure more visible than in oncology.

Only 3 out of 123 cancer drugs approved between 2013 and 2022 met all four of the FDA’s basic scientific standards.

Most—81%—were approved based on surrogate endpoints like tumour shrinkage, without any evidence that they improved survival or quality of life.

Take Copiktra, for example—a drug approved in 2018 for blood cancers. The FDA gave it the green light based on improved “progression-free survival,” a measure of how long a tumour stays stable.

But a review of post-marketing data showed that patients taking Copiktra died 11 months earlier than those on a comparator drug.

It took six years after those studies showed the drug reduced patients’ survival for the FDA to warn the public that Copiktra should not be used as a first- or second-line treatment for certain types of leukaemia and lymphoma, citing “an increased risk of treatment-related mortality.”

Elmiron: Ineffective, Dangerous—And Still on the Market

Another striking case is Elmiron, approved in 1996 for interstitial cystitis—a painful bladder condition.

The FDA authorized it based on “close to zero data,” on the condition that the company conduct a follow-up study to determine whether it actually worked.

That study wasn’t completed for 18 years—and when it was, it showed Elmiron was no better than placebo.

In the meantime, hundreds of patients suffered vision loss or blindness. Others were hospitalized with colitis. Some died.

Yet Elmiron is still on the market today. Doctors continue to prescribe it.

“Hundreds of thousands of patients have been exposed to the drug, and the American Urological Association lists it as the only FDA-approved medication for interstitial cystitis,” Lenzer and Brownlee reported.

“Dangling Approvals” and Regulatory Paralysis

The FDA even has a term—”dangling approvals”—for drugs that remain on the market despite failed or missing follow-up trials.

One notorious case is Avastin, approved in 2008 for metastatic breast cancer.

It was fast-tracked, again, based on ‘progression-free survival.’ But after five clinical trials showed no improvement in overall survival—and raised serious safety concerns—the FDA moved to revoke its approval for metastatic breast cancer.

The backlash was intense.

Drug companies and patient advocacy groups launched a campaign to keep Avastin on the market. FDA staff received violent threats. Police were posted outside the agency’s building.

The fallout was so severe that for more than two decades afterwards, the FDA did not initiate another involuntary drug withdrawal in the face of industry opposition.

Billions Wasted, Thousands Harmed

Between 2018 and 2021, US taxpayers—through Medicare and Medicaid—paid $18 billion for drugs approved under the condition that follow-up studies would be conducted. Many never were.

The cost in lives is even higher.

A 2015 study found that 86% of cancer drugs approved between 2008 and 2012 based on surrogate outcomes showed no evidence that they helped patients live longer.

An estimated 128,000 Americans die each year from the effects of properly prescribed medications—excluding opioid overdoses. That’s more than all deaths from illegal drugs combined.

A 2024 analysis by Danish physician Peter Gøtzsche found that adverse effects from prescription medicines now rank among the top three causes of death globally.

Doctors Misled by the Drug Labels

Despite the scale of the problem, most patients—and most doctors—have no idea.

A 2016 survey published in JAMA asked practising physicians a simple question—what does FDA approval actually mean?

Only 6% got it right.

The rest assumed that it meant the drug had shown clear, clinically meaningful benefits—such as helping patients live longer or feel better—and that the data was statistically sound.

But the FDA requires none of that.

Drugs can be approved based on a single small study, a surrogate endpoint, or marginal statistical findings. Labels are often based on limited data, yet many doctors take them at face value.

Harvard researcher Aaron Kesselheim, who led the survey, said the results were “disappointing, but not entirely surprising,” noting that few doctors are taught about how the FDA’s regulatory process actually works.

Instead, physicians often rely on labels, marketing, or assumptions—believing that if the FDA has authorized a drug, it must be both safe and effective.

But as The Lever investigation shows, that is not a safe assumption.

And without that knowledge, even well-meaning physicians may prescribe drugs that do little good—and cause real harm.

Who Is the FDA Working for?

In interviews with more than 100 experts, patients, and former regulators, Lenzer and Brownlee found widespread concern that the FDA has lost its way.

Many pointed to the agency’s dependence on industry money. A BMJ investigation in 2022 found that user fees now fund two-thirds of the FDA’s drug review budget—raising serious questions about independence.

Yale physician and regulatory expert Reshma Ramachandran said the system is in urgent need of reform.

“We need an agency that’s independent from the industry it regulates and that uses high-quality science to assess the safety and efficacy of new drugs,” she told The Lever. “Without that, we might as well go back to the days of snake oil and patent medicines.”

For now, patients remain unwitting participants in a vast, unspoken experiment—taking drugs that may never have been properly tested, trusting a regulator that too often fails to protect them.

And as Lenzer and Brownlee conclude, that trust is increasingly misplaced.

Republished from the author’s Substack

 

Author

Maryanne Demasi, 2023 Brownstone Fellow, is an investigative medical reporter with a PhD in rheumatology, who writes for online media and top tiered medical journals. For over a decade, she produced TV documentaries for the Australian Broadcasting Corporation (ABC) and has worked as a speechwriter and political advisor for the South Australian Science Minister.

Continue Reading

Brownstone Institute

Anthony Fauci Gets Demolished by White House in New Covid Update

Published on

From the Brownstone Institute

By  Ian Miller 

Anthony Fauci must be furious.

He spent years proudly being the public face of the country’s response to the Covid-19 pandemic. He did, however, flip-flop on almost every major issue, seamlessly managing to shift his guidance based on current political whims and an enormous desire to coerce behavior.

Nowhere was this more obvious than his dictates on masks. If you recall, in February 2020, Fauci infamously stated on 60 Minutes that masks didn’t work. That they didn’t provide the protection people thought they did, there were gaps in the fit, and wearing masks could actually make things worse by encouraging wearers to touch their face.

Just a few months later, he did a 180, then backtracked by making up a post-hoc justification for his initial remarks. Laughably, Fauci said that he recommended against masks to protect supply for healthcare workers, as if hospitals would ever buy cloth masks on Amazon like the general public.

Later in interviews, he guaranteed that cities or states that listened to his advice would fare better than those that didn’t. Masks would limit Covid transmission so effectively, he believed, that it would be immediately obvious which states had mandates and which didn’t. It was obvious, but not in the way he expected.

And now, finally, after years of being proven wrong, the White House has officially and thoroughly rebuked Fauci in every conceivable way.

White House Covid Page Points Out Fauci’s Duplicitous Guidance

A new White House official page points out, in detail, exactly where Fauci and the public health expert class went wrong on Covid.

It starts by laying out the case for the lab-leak origin of the coronavirus, with explanations of how Fauci and his partners misled the public by obscuring information and evidence. How they used the “FOIA lady” to hide emails, used private communications to avoid scrutiny, and downplayed the conduct of EcoHealth Alliance because they helped fund it.

They roast the World Health Organization for caving to China and attempting to broaden its powers in the aftermath of “abject failure.”

“The WHO’s response to the COVID-19 pandemic was an abject failure because it caved to pressure from the Chinese Communist Party and placed China’s political interests ahead of its international duties. Further, the WHO’s newest effort to solve the problems exacerbated by the COVID-19 pandemic — via a “Pandemic Treaty” — may harm the United States,” the site reads.

Social distancing is criticized, correctly pointing out that Fauci testified that there was no scientific data or evidence to support their specific recommendations.

“The ‘6 feet apart’ social distancing recommendation — which shut down schools and small business across the country — was arbitrary and not based on science. During closed door testimony, Dr. Fauci testified that the guidance ‘sort of just appeared.’”

There’s another section demolishing the extended lockdowns that came into effect in blue states like California, Illinois, and New York. Even the initial lockdown, the “15 Days to Slow the Spread,” was a poorly reasoned policy that had no chance of working; extended closures were immensely harmful with no demonstrable benefit.

“Prolonged lockdowns caused immeasurable harm to not only the American economy, but also to the mental and physical health of Americans, with a particularly negative effect on younger citizens. Rather than prioritizing the protection of the most vulnerable populations, federal and state government policies forced millions of Americans to forgo crucial elements of a healthy and financially sound life,” it says.

Then there’s the good stuff: mask mandates. While there’s plenty more detail that could be added, it’s immensely rewarding to see, finally, the truth on an official White House website. Masks don’t work. There’s no evidence supporting mandates, and public health, especially Fauci, flip-flopped without supporting data.

“There was no conclusive evidence that masks effectively protected Americans from COVID-19. Public health officials flipped-flopped on the efficacy of masks without providing Americans scientific data — causing a massive uptick in public distrust.”

This is inarguably true. There were no new studies or data justifying the flip-flop, just wishful thinking and guessing based on results in Asia. It was an inexcusable, world-changing policy that had no basis in evidence, but was treated as equivalent to gospel truth by a willing media and left-wing politicians.

Over time, the CDC and Fauci relied on ridiculous “studies” that were quickly debunked, anecdotes, and ever-shifting goal posts. Wear one cloth mask turned to wear a surgical mask. That turned into “wear two masks,” then wear an N95, then wear two N95s.

All the while ignoring that jurisdictions that tried “high-quality” mask mandates also failed in spectacular fashion.

And that the only high-quality evidence review on masking confirmed no masks worked, even N95s, to prevent Covid transmission, as well as hearing that the CDC knew masks didn’t work anyway.

The website ends with a complete and thorough rebuke of the public health establishment and the Biden administration’s disastrous efforts to censor those who disagreed.

“Public health officials often mislead the American people through conflicting messaging, knee-jerk reactions, and a lack of transparency. Most egregiously, the federal government demonized alternative treatments and disfavored narratives, such as the lab-leak theory, in a shameful effort to coerce and control the American people’s health decisions.

When those efforts failed, the Biden Administration resorted to ‘outright censorship—coercing and colluding with the world’s largest social media companies to censor all COVID-19-related dissent.’”

About time these truths are acknowledged in a public, authoritative manner. Masks don’t work. Lockdowns don’t work. Fauci lied and helped cover up damning evidence.

If only this website had been available years ago.

Though, of course, knowing the media’s political beliefs, they’d have ignored it then, too.

Republished from the author’s Substack

Author

Ian Miller is the author of “Unmasked: The Global Failure of COVID Mask Mandates.” His work has been featured on national television broadcasts, national and international news publications and referenced in multiple best selling books covering the pandemic. He writes a Substack newsletter, also titled “Unmasked.”

Continue Reading

Trending

X